Fellowship · ATLANTA, GA
Sponsored by Emory University School of Medicine
Overview of Changes to the Clinical and Laboratory Standards Institute Performance Standards for Antimicrobial Susceptibility Testing, M100, 31st Edition.
Journal of clinical microbiology · 2021 · 1,389 citations · Audrey Schuetz
SER-109, an Oral Microbiome Therapy for Recurrent Clostridioides difficile Infection.
The New England journal of medicine · 2022 · 459 citations · Colleen Kraft
Overview of changes in the Clinical and Laboratory Standards Institute Performance Standards for Antimicrobial Susceptibility Testing: M100 32nd and 33rd editions.
Journal of clinical microbiology · 2025 · 93 citations · Audrey Schuetz
Effectiveness of ceftazidime-avibactam versus ceftolozane-tazobactam for multidrug-resistant Pseudomonas aeruginosa infections in the USA (CACTUS): a multicentre, retrospective, observational study.
The Lancet. Infectious diseases · 2025 · 62 citations · Ahmed Babiker
Inappropriate empirical antibiotic therapy for bloodstream infections based on discordant in-vitro susceptibilities: a retrospective cohort analysis of prevalence, predictors, and mortality risk in US hospitals.
The Lancet. Infectious diseases · 2021 · 226 citations · Ahmed Babiker
Early cellular mechanisms of type I interferon-driven susceptibility to tuberculosis.
Cell · 2023 · 127 citations ·
Association Between Caseload Surge and COVID-19 Survival in 558 U.S. Hospitals, March to August 2020.
Annals of internal medicine · 2021 · 182 citations · Ahmed Babiker
Fecal microbiota transplantation promotes reduction of antimicrobial resistance by strain replacement.
Science translational medicine · 2023 · 99 citations · Ahmed Babiker, Colleen Kraft